Ksenia Blinova

Office of Science and Engineering Laboratories,
Center for Devices and Radiological Health,
Office of Science and Engineering Laboratories, Center for Devices and Radiological Health

U.S. Food and Drug Administration

BIOGRAPHY

Ksenia Blinova has not added Biography.

If you are Ksenia Blinova and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias.

Toxicological sciences : an official journal of the Society of Toxicology Jan, 2017 | Pubmed ID: 27701120

Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.

Circulation Apr, 2017 | Pubmed ID: 28213480

Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessment.

Journal of pharmacological and toxicological methods , 2018 | Pubmed ID: 29155283

International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment.

Cell reports Sep, 2018 | Pubmed ID: 30257217

Repolarization studies using human stem cell-derived cardiomyocytes: Validation studies and best practice recommendations.

Regulatory toxicology and pharmacology : RTP , | Pubmed ID: 32822771

Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs).

International journal of molecular sciences Mar, 2022 | Pubmed ID: 35328619

Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models.

Frontiers in physiology , 2022 | Pubmed ID: 36439258

INSTITUTIONS

U.S. Food and Drug Administration

Center for Devices and Radiological Health, U.S. Food and Drug Administration

JOVE ARTICLES

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Tromondae K. Feaster¹,

Maura Casciola¹,

Akshay Narkar¹,

Ksenia Blinova¹

¹Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration

Bioengineering

Comprehensive Collection of Current Methods for Contractility and Electrophysiology Recordings in Human Cardiac Cells

Ksenia Blinova¹,

Jennifer Pierson²,

Akshay Narkar¹

¹, Center for Devices and Radiological Health, U.S. Food and Drug Administration,

², Health and Environmental Sciences Institute

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

Education

JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Faculty Site

Authors

Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit

Librarians

Overview
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center
JoVE Sitemap

We use cookies to enhance your experience on our website.

By continuing to use our website or clicking “Continue”, you are agreeing to accept our cookies.

Learn More

Ksenia Blinova

Office of Science and Engineering Laboratories,Center for Devices and Radiological Health,Office of Science and Engineering Laboratories, Center for Devices and Radiological Health

U.S. Food and Drug Administration

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Comprehensive Collection of Current Methods for Contractility and Electrophysiology Recordings in Human Cardiac Cells

Office of Science and Engineering Laboratories,
Center for Devices and Radiological Health,
Office of Science and Engineering Laboratories, Center for Devices and Radiological Health